Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now later-stage tilt small index

Cesarean Delivery: later-stage trial registry

6 of 11 indexed Cesarean Delivery trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Cesarean Delivery: 11 US clinical trials tracked, 6 recruiting.

Cesarean Delivery is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 2 of these trials.

Enrollment posture brief

Registry condition cesarean-delivery

OPEN 6 | RECR 55% | LATE 4 | EARLY 0 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)

Acute Pancreatitis81.8%Cesarean Delivery (this)55%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Cesarean Delivery

Cesarean Delivery lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cesarean Delivery on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cesarean Delivery is recruiting above its size-band peers.

    6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cesarean Delivery research.

    Columbia University accounts for 2 of 11 trials (18.2%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cesarean Delivery enrolment sits around 120 participants.

    Median target enrolment is 120 among the 11 trials that report a genuine target (sentinel values excluded). 2 of those (18.2%) plan for fewer than 100 participants.

  4. Cesarean Delivery research is mostly interventional.

    8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 43

Open and recent trials

11 total, page 1 of 1

RECRUITING Phase 3 8,000 participants

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

The George Washington University Biostatistics Center

NCT06605118

RECRUITING 5,000 participants

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Yale University

NCT06030063

RECRUITING Phase 4 825 participants

Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies

Thomas Jefferson University

NCT07102641

RECRUITING Phase 4 120 participants

COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block

University of Tennessee

NCT06925152

RECRUITING NA 100 participants

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin

University of Pennsylvania

NCT07006896

RECRUITING NA 52 participants

Post-Operative Cesarean Section Cosmesis

Wake Forest University Health Sciences

NCT06412978

ACTIVE NOT RECRUITING NA 20,000 participants

IC-CS Risk: Patient Outcomes

University of Pennsylvania

NCT06488092

COMPLETED 494 participants

Postpartum Opioid Prescribing Patterns and Patient Utilization

Northwestern University

NCT03030742

COMPLETED NA 113 participants

Delayed Cord Clamping at Term Cesarean

Columbia University

NCT03150641

COMPLETED 101 participants

A Retrospective Comparison of Neonatal Acid-base Status After CD Before January, 2015 and After January, 2016

Columbia University

NCT03455660

COMPLETED Phase 4 23 participants

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Michael Stitely

NCT01755026

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 3

Named interventions

Most-linked intervention names on Cesarean Delivery records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

cefazolin Drug
1 trials
Umbilical cord clamping Procedure
1 trials
Cesarean Risk Calculator Other
1 trials
Standard of Care Preoperative antibiotics Drug
1 trials
Azithromycin Injection Drug
1 trials
Foley balloon Device
1 trials
NSAID (Ketorolac/Ibuprofen) Drug
1 trials
Placebo arm Drug
1 trials

US sites by state

Facility locations filed on Cesarean Delivery trials. A trial with sites in several states counts in each.

Pennsylvania 4 trials
New York 4 trials
Illinois 3 trials
Utah 2 trials
Ohio 2 trials
North Carolina 2 trials
California 2 trials
West Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cesarean Delivery page

11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cesarean Delivery condition card totals 11 registered trials; most-linked intervention cefazolin; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.